寿仙谷: 寿仙谷关于“寿22转债”2025年跟踪评级结果的公告

Core Viewpoint - Zhejiang Shouxiangu Pharmaceutical Co., Ltd. maintains its credit rating of "AA-" for both its corporate and convertible bonds, with a stable outlook as per the latest tracking report by Zhongzheng Pengyuan [1][2]. Group 1: Credit Rating Details - The previous credit rating for the company and its convertible bonds was "AA-", with a stable outlook, issued on June 25, 2024 [1][2]. - The latest tracking credit rating report was issued on June 20, 2025, confirming the ratings remain unchanged [2]. Group 2: Regulatory Compliance - The company conducted the credit rating in accordance with the "Measures for the Issuance and Trading of Corporate Bonds" and the "Listing Rules for Corporate Bonds on the Shanghai Stock Exchange" [1].